Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4
Brain and Development · 2023
DOI: 10.1016/j.braindev.2022.12.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Development, 2023. Verfasst von Kazuki Segawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Neurophysiology, Department of Clinical Laboratory and Biomedical Sciences, Division of Health Sciences, Osaka University Graduate School of…. Hauptthemen laut MEDLINE: Paralysis, Hyperkalemic Periodic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Mochida Memorial Foundation for Medical and Pharmaceutical Research, Takeda Science Foundation, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
BACKGROUND: Hyperkalemic periodic paralysis (HyperPP) is an autosomal dominantly inherited disease characterized by episodic paralytic attacks with hyperkalemia, and is caused by mutations of the SCN4A gene encoding the skeletal muscle type voltage-gated sodium channel Nav1.4. The pathological mechanism of HyperPP was suggested to be associated with gain-of-function changes for Nav1.4 gating, some of which are defects of slow inactivation. CASE PRESENTATION & METHODS: We identified a HyperPP family consisting of the proband and his mother, who showed a novel heterozygous SCN4A variant, p.V792G, in an inner pore lesion of segment 6 in Domain II of Nav1.4. Clinical and neurophysiological evaluations were conducted for the proband and his mother. We explored the pathogenesis of the variant by whole-cell patch clamp technique using HEK293T cells expressing the mutant Nav1.4 channel. RESULTS: Functional analysis of Nav1.4 with the V792G mutation revealed a hyperpolarized shift of voltage-dependent activation and fast inactivation. Moreover, steady-state slow inactivation in V792G was impaired with larger residual currents in comparison with wild-type Nav1.4. CONCLUSION: V792G in SCN4A is a pathogenic variant associated with the HyperPP phenotype and the inner pore lesion of Nav1.4 plays a crucial role in slow inactivation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Neurophysiology, Department of Clinical Laboratory and Biomedical Sciences, Division of Health Sciences, Osaka University Graduate School of Medicine, Japan.
- Department of Pediatrics, Kobe University Graduate School of Medicine, Japan.
- Clinical Neurophysiology, Department of Clinical Laboratory and Biomedical Sciences, Division of Health Sciences, Osaka University Graduate School of Medicine, Japan. Electronic address: tomoya-k@sahs.med.osaka-u.ac.jp.
Förderung
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Takeda Science Foundation
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Ministry of Health, Labour and Welfare
Zitieren
APA
Segawa, K., Nishiyama, M., Mori, I., Kubota, T., & Takahashi, M. P. (2023). Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4. Brain and Development. https://doi.org/10.1016/j.braindev.2022.12.003
Vancouver
Segawa K, Nishiyama M, Mori I, Kubota T, Takahashi MP. Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4. Brain and Development. 2023. doi:10.1016/j.braindev.2022.12.003
BibTeX
@article{Segawa2023,
author = {Segawa, Kazuki and Nishiyama, Masahiro and Mori, Itsuki and Kubota, Tomoya and Takahashi, Masanori P},
title = {Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4},
journal = {Brain and Development},
year = {2023},
doi = {10.1016/j.braindev.2022.12.003}
}
EUVIMED